The precise pathophysiological link between the vaccine and VITT is unclear, but the thrombocytopenia can be accounted for by antibodies to platelet factor 4, as are present in heparin-induced thrombocytopenia. The gene discussed is PF4; the disease is Thrombocytopenia.